Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

Thirty-five cases of adverse reactions or serious side effects were reported in Korea within the first month of the release ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual ...

njectable medications like Mounjaro (Tirzepatide) and Wegovy (Semaglutide) have been game changers for many people on a weight loss journey. Both Mounjaro vs Wegovy work on similar pathways to help ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

Struggling with obesity is no walk in the park. It crushes your self-esteem and messes with your body image, not to mention that some people might even develop anxiety and depression. Recent ...

One in 20 Brits taking Mounjaro or Wegovy weight loss medications have been advised to avoid festive foods like pigs in ...

In November, Mounjaro clocked Rs 108 crore in sales, making it the number 1 brand in the IPM, reflecting sustained momentum ...

Novo Nordisk's Wegovy consumption jumped 70% after price cuts, lifting share in November. Eli Lilly's Mounjaro still led anti ...